Loading clinical trials...
Loading clinical trials...
Ibandronate Versus Placebo as add-on to Active Vitamin D and Calcium in the Prevention of Bone Loss After Renal Transplantation.
Conditions
Interventions
Placebo
Ibandronate
Locations
1
Norway
Rikshospitalet-Radiumhospitalet Medical Center
Oslo, Norway
Start Date
January 1, 2007
Primary Completion Date
December 1, 2009
Completion Date
December 1, 2010
Last Updated
March 24, 2010
NCT07294183
NCT07090512
NCT05086003
NCT07392996
NCT03719339
NCT03726307
Lead Sponsor
Smerud Medical Research International AS
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions